Article Abstract

Bioresorbable scaffolds: should we stay simple or go complex?

Authors: Luis Ortega-Paz, Salvatore Brugaletta, Hector M. Garcia-Garcia, Manel Sabaté


From its inception, scaffolding the coronary artery with bioresorbable scaffolds (BRS) has been projected as the fourth revolution in interventional cardiology, primarily designed to overcome drug-eluting stents (DES) limitations (1). This technology aims at proving some presumptive advantages over DES such as: restoration of coronary physiology and vascular adaptive responses; to obtain late lumen gain and plaque regression; and to decrease late and very-late events (1).